-
2 Reasons Pfizer's Stock Beat the Field in 2016
Post on 1/10/17
-
Is Celgene Simply the Best Biotech Stock on the Planet?
Post on 1/10/17
-
Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases
Post on 1/9/17
-
Aridis Pharmaceuticals Receives Award from the Cystic Fibrosis Foundation Therapeutics to Advance Panaecin
Post on 1/9/17
-
Advaxis Provides 2017 Business Outlook
Post on 1/9/17
-
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer
Post on 1/9/17
-
Celgene: A Core Biotech Holding For 2017 And Beyond
Post on 1/9/17
-
Will Johnson & Johnson Shock Investors with a Spin-off in 2017?
Post on 1/9/17
-
Why Biotech Titans Are Clashing Over Cholesterol
Post on 1/9/17
-
American Media Announces Creation Of The AMI Fitness Group
Post on 1/8/17
-
Lewis Drug and iMedicare Announce Partnership
Post on 1/8/17
-
Celldex Therapeutics, Inc.'s 3 Best Moves in 2016
Post on 1/6/17
-
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 1/5/17
-
Bristol-Myers Squibb Announces Immunotherapy Clinical Collaboration with Janssen
Post on 1/5/17
-
Register By January 15 For The Valley Table’s Spring 2017 Hudson Valley Restaurant Week
Post on 1/5/17
-
Did Biogen Just Throw in the Towel to Celgene?
Post on 1/5/17
-
Blink Fitness Opens Its Newest Bronx Location In Gun Hill
Post on 1/4/17
-
Lewis Drug and iMedicare Announce Partnership to Begin Offering the iMedicare Platform in Its Locations
Post on 1/4/17
-
Soligenix Announces Extension of Development Agreement with Emergent BioSolutions
Post on 1/3/17
-
Interpace Diagnostics Announces Agreement with Blue Cross Blue Shield
Post on 1/3/17
-
Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock
Post on 1/3/17
-
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease
Post on 1/3/17
-
Interpace Diagnostics Group Announces 1-for-10 Reverse Split
Post on 1/1/17
-
Rasna Therapeutics Closes Private Placement of $2 Million
Post on 12/27/16
-
TSO3 Enters into Strategic Partner Facility Agreement with The Mount Sinai Hospital
Post on 12/23/16
New York
